U.S. markets open in 54 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.50+0.03 (+0.46%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/16/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
122.11M171.89M190.09M79.45M97.98M39.59M
Enterprise Value 3
98.81M144.50M159.60M67.80M85.50M31.89M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
5.286.616.397.057.355.20
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-7.16-40.00-37.44-20.61-32.41-13.97

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 332.38%
S&P500 52-Week Change 341.30%
52 Week High 310.88
52 Week Low 33.77
50-Day Moving Average 39.05
200-Day Moving Average 38.17

Share Statistics

Avg Vol (3 month) 3118.25k
Avg Vol (10 day) 3148.83k
Shares Outstanding 518.79M
Implied Shares Outstanding 6N/A
Float 16.4M
% Held by Insiders 17.90%
% Held by Institutions 133.94%
Shares Short (Apr 29, 2021) 4163.99k
Short Ratio (Apr 29, 2021) 42.02
Short % of Float (Apr 29, 2021) 40.89%
Short % of Shares Outstanding (Apr 29, 2021) 40.87%
Shares Short (prior month Mar 30, 2021) 4172.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 14, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov 14, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.92%
Return on Equity (ttm)-73.98%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.89M
Net Income Avi to Common (ttm)-13.49M
Diluted EPS (ttm)-0.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.4M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)102k
Total Debt/Equity (mrq)0.44
Current Ratio (mrq)20.54
Book Value Per Share (mrq)1.23

Cash Flow Statement

Operating Cash Flow (ttm)-10.52M
Levered Free Cash Flow (ttm)-5.93M